Introducing the GenapSys Sequencer
Sequencing without compromise

GS111 Sequencer

The GenapSys™ Sequencer is exceptionally accurate, incredibly scalable, and amazingly affordable.

SEE THE NEW SEQUENCER

Innovative electrical detection enables accurate, scalable and affordable sequencing.

GenapSys has developed a novel electrical-based platform capable of accurately detecting single base incorporations. The semiconductor chip-based detection modality allows the system to be compact, scalable, and affordable.

DISCOVER OUR TECHNOLOGY

GenapSys technology achieves
>80% of bases >Q30

The GenapSys platform has been successfully demonstrated in a range of
applications that include targeted sequencing to elucidate
both germline and somatic mutations, as well as sequencing a range of small genomes.

SEE THE DATA

The latest GenapSys news & upcoming events.

GenapSys Raises $90M Series C Led by Foresite Capital to Commercialize Its Breakthrough Electronic Gene Sequencer

Redwood City, CA (Nov. 20, 2019) -- GenapSys Inc. announced today that it has completed a $90 million funding round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate sequencer ever developed.
Read more >

March 5, 2019—GEN | Sequencing Platforms Make a Splash on Marco Island at AGBT Meeting

Despite single cell RNA technologies being front and center at the AGBT meeting in Marco Island, Florida, last week, two new DNA sequencing technology presentations from MGI and Genapsys created their own buzz. Both companies presented big plans in the sequencing space, but they are far too new on the scene to predict disruption of …
Read more >

ABRF 2020 Annual Meeting

Meet GenapSys at the Association of Biomolecular Resource Facilities
Read more >

Get in touch with GenapSys.

Receive the latest news or request a quote.